Concepedia

Standard Versus Low-Dose Weight-Adjusted Heparin in Patients Treated With the Platelet Glycoprotein IIb/IIIa Receptor Antibody Fragment Abciximab (c7E3 Fab) During Percutaneous Coronary Revascularization

A. Michael Lincoff, James E. Tcheng, Robert M. Califf, Theodore A. Bass, Jeffrey J. Popma, Paul S. Teirstein, Neal S. Kleiman, Larry J. Hattel, H. Vernon Anderson, James J. Ferguson,

The American Journal of Cardiology · 1997 · 139 citations · 12 references

DOI

Concepts

References

12

Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary Angioplasty

The EPIC Investigators · New England Journal of Medicine · 1994 · 2.6K citations · Full text

, , +17

Thrombolysis in myocardial infarction (TIMI) trial—Phase I: Hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase

Anupama Rao, Craig M. Pratt, Andrew Berke et al. · Journal of the American College of Cardiology · 1988 · 988 citations

, , +17

Pharmacodynamics of chimeric glycoprotein IIb/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplasty.

James E. Tcheng, Stephen G. Ellis, Barry S. George et al. · Circulation · 1994 · 415 citations · Full text

, , +17

Peripheral vascular complications after conventional and complex percutaneous coronary interventional procedures

David W.M. Muller, Kenath J. Shamir, Stephen G. Ellis et al. · The American Journal of Cardiology · 1992 · 297 citations · Full text

, , +14

Identification and preliminary validation of predictors of major bleeding in hospitalized patients starting anticoagulant therapy

C. Seth Landefeld, E. Francis Cook, Margaret Flatley et al. · The American Journal of Medicine · 1987 · 266 citations

, , +13